Clinical Trial Detail

NCT ID NCT03695471
Title Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

mycosis fungoides

Sezary's disease

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.